http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017502994-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
filingDate 2015-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2017502994-A
titleOfInvention 1- (Triazin-3-yl / pyridazin-3-yl) -piperidine / piperazine derivatives and compositions thereof for inhibiting the activity of SHP2
abstract The present invention provides compounds of formula I that can inhibit the activity of SHP2, wherein Y 1 , Y 2 , Y 3 , R 1 , R 2a , R 2b , R 3a , R 3b , R 4b , R 4b , R 5a and R 5b are defined in the Summary of the Invention). The invention further provides methods for preparing the compounds of the invention, pharmaceutical preparations containing such compounds, and methods of using such compounds and compositions in the management of diseases or disorders associated with abnormal activity of SHP2. I will provide a. [Chemical 1] [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11673901-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020536881-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11673896-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11661401-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7284830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019039390-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702411-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021042231-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11739093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022527796-A
priorityDate 2014-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010518014-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007534687-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012508260-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012027495-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0799617-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013502424-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008031556-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010521438-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467226674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118249272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118249026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433120020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118240399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433442847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429694517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118248912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432440131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163456242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465644408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118249249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465007132

Total number of triples: 64.